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Intracranial pressureRecently tremendous progress has beenmade in studying choroid plexus (CP) physiology andpathophysiology; and
correcting several misconceptions about the CP. Speciﬁcally, the details of how CP, a locus of the blood–CSF barrier
(BCSFB), secretes and puriﬁes CSF, generates intracranial pressure (ICP), maintains CSF ion homeostasis, and
provides micronutrients, proteins and hormones for neuronal and glial development, maintenance and function,
are being understood on a molecular level. Unequivocal evidence that the CP secretory epithelium is the predomi-
nant supplier of CSF for the ventricles comes frommultiple lines: uptake kinetics of tracer 22Na and 36Cl penetration
fromblood toCSF, autoradiographicmappingof rapid 22Na and 36Cl permeation (highpermeability coefﬁcients) into
the cerebroventricles, CSF sampling from several different in vivo and in vitro CP preparations, CP hyperplasia that
increases CSF formation and ICP; and in vitro analysis of CP ability to transport molecules (with expected direction-
ality) and actively secrete ﬂuid against an hydrostatic ﬂuid column. Furthermore, clinical support for this CP–CSF
model comes from neurosurgical procedures to remove lateral ventricle CPs in hydrocephalic children to reduce
CSF formation, thereby relieving elevated ICP. In terms of micronutrient transport, ascorbic acid, folate and other
essential factors are transported by speciﬁc (cloned) carriers across CP into ventricular CSF, fromwhich they pene-
trate across the ependyma and pia mater deeply into the brain to support its viability and function. Without these
choroidal functions, severe neurological disease and even death can occur. In terms of efﬂux or clearance transport,
the active carriers (many of which have been cloned and expressed) in the CP basolateral and apical membranes
perform regulatory removal of some metabolites (e.g. choline) and certain drugs (e.g. antibiotics like penicillin)
from CSF, thus reducing agents such as penicillin to sub-therapeutic levels. Altogether, these multiple transport
and secretory functions in CP support CSF homeostasis and ﬂuid dynamics essential for brain function.
© 2015 Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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The purposes of this review are to summarize newer information
about the structure and function of the adult choroid plexus (CP), focus-
ing on issues with clinical relevance, and to correct several misconcep-
tions in the literature. Particularly, we stress the predominant role of
the CP in secreting ventricular cerebrospinal ﬂuid (CSF) that maintains
ICP and bulk ﬂow down the neuraxis into the subarachnoid space. Our
emphasis will be on humans greater than age two since the function
of the CP in younger children awaits elucidation (Bateman and Brown,
2012). In this section, we underscore key points expanded upon in the
body of the text.
The living anatomy of the CP is very revealing. As aptly remarked by
Wei Zheng, “In the human brain at autopsy duringwhich the CSF is usu-
ally completely drained, the choroid plexus can be seen to extend along
the ﬂoor of the lateral ventricles, hang down from the roof of the third
ventricle, and overly the roof of the fourth ventricle. The size of the tis-
sue in one ventricle when in a dry, condensed state appears to be noth-
ingmore than that of an index ﬁnger. These autopsy impressions, which
have over the years become the popular perception among many neu-
ropathologists, can be dreadfully misleading and may lead to misjudg-
ments of the function of this tissue. Recent advances in technology
have enabled amicro-video probe to be inserted directly into the lateral
ventricles. The vivid images illustrate that the live choroid plexus per-
vades the ventricles, stretching and pulsating in concert with the heart
pulse. To better understand this, it may be helpful to make an analogy
between the choroid plexus and a ﬁshnet. The ﬁshnet occupies barely
one corner of the ﬁshing boat; yet upon spreading in the water, it ex-
tends to cover a large area. Likewise, in the life situation where the
brain ventricles are full of CSF, the choroid plexus expands to ﬁll nearly
all the cerebral ventricles. Unlike the ﬁshnet, however, the plexus tissue
possesseswell-developed brush-type borders, i.e., microvilli, on the api-
cal epithelial surface. These brush borders further protrude into the CSF
and increase the choroidal epithelial surface area, enabling rapid and ef-
ﬁcient delivery of the CSF as well as other material included with the
CSF secretion” (Zheng and Chodobski, 2005).
Notwithstanding recent deﬁnitive data, reference is still made (Tang
et al., 2014) to older erroneous histological data claiming that the CP
apical surface area is small and therefore not physiologically important
for mediating brain-wide molecular distribution (Pardridge, 2011).
However, in fact, as discussed below CP surface area is substantial,
~25 to 50% the size of the inner capillary surface area of the brain. This
provides an enormous surface area for performing amyriad of choroidal
transport functions. Moreover, the large surface area of brain capillaries
and CP epithelial cells also allowswater to diffuse freely andbidirection-
ally between blood, brain and CSF. Sweet et al. (1950) ﬁrst showed this
phenomenon in humans. Subsequently Oldendorf demonstrated in rats
that greater than 50% of plasma water exchanges with the water of
brain and CSF in a single pass of blood through the brain (Oldendorf,
1970). The exact mechanism of this huge bidirectional ﬂux of water
through the brain capillaries and CP is unknown since in adults there
are no obvious aquaporins in brain capillary endothelium or on the
basal side of the choroidal epithelium (Speake et al., 2003). We also
know that secretion of CSF is volumetrically b1/100 that of CNS water
diffusional exchange (Bateman and Brown, 2012; Brinker et al., 2014).
The preponderance of CSF is formed by CP and consists of salts, micro-
nutrient vitamins, secreted proteins, hormones and water pulled along
passively to maintain osmotic equilibrium, as described below.One group states that CP does not produce CSF (Oreskovic and
Klarica, 2010), a result inconsistent with over 60 years of data obtained
for animals and humans. Among the multiple experiments countering
this view, we cite three recent examples. First, in accordance with the
most powerful of the causality arguments of John Stuart Mill, the
method of commitment variation, often termed dose–response causali-
ty in pharmacology, one would predict that more CSF would be pro-
duced in CP hyperplasia (Smith et al., 2007) if the CP produces CSF. As
part of a deﬁnitive review of CP hyperplasia cases, Hallaert and col-
leagues present as an example (Hallaert et al., 2012), a very well-
studied case of a 3-year-old child with communicating hydrocephalus
in which the lateral CP, but not the third and fourth ventricular CPs,
were enlarged on MRI due to a genetic defect; with the external drain-
age system at the level of the foramen of Monroe, this 10 kg child copi-
ously produced 2 l of CSF per day! On removal of the two enlarged
lateral plexuses, the histological appearance of the tissue was normal
and the child's CSF overproduction was prevented. There is no doubt
that her CP secreted CSF in this case. Similarly, inmany other cases of in-
creased ICP (e.g., hydrocephalus) due to relative or absolute overpro-
duction of CSF, as discussed below, removal of the lateral CP tissues is
beneﬁcial by substantially lowering the ICP.
Secondly, for decades we have also known that the CP containsmul-
tiple transporters capable of transferring Na+, Cl−, and HCO3− from
blood into CSF across the CP — a typical secretory epithelium. Recently,
in one example of a sophisticated study in mice (Kao et al., 2011), the
investigators knocked out the CP transporter sla4a5 that transports
NaHCO3 into CSF. Sla4a5 exists only on the apical surface of CP, appar-
ently nowhere else in the CNS. These sla4a5 knockout (KO) mice had
a ventricular volume and CSF pressure only ~25% of normal. Moreover,
their CSF had a lower HCO3− concentration, as expected. This study
clearly showed that the CP, with the aid of sla4a5 and other ion trans-
porters, produces HCO3−-containing CSF. And thirdly, the CP epithelial
monolayer in an in vitro trans-well actively transports not only vitamin
C (Angelow et al., 2003) but also “CSF” from the basal to the apical (ven-
tricular) side against a considerable hydrostatic pressure gradient
(Hakvoort et al., 1998). Such ﬂuid pumping against pressure clearly
mimics the in vivo situation of elevated ICP in hydrocephalus.
Another set of concepts needing revision is that drugs and nutrients
pass into and out of CSF mainly by passive forces largely dependent on
molecularweight, ionic charge and lipid solubility; and donot penetrate
deeply into the substance of the brain from CSF (Nagaraja et al., 2005;
Pardridge, 2011, 2012). These concepts need qualiﬁcation in order to
promote precise understanding and sound therapeutic regimens, as
discussed below.
Anatomy of choroid plexus: structural–functional relationships
Choroid plexus ultrastructure is similar in the lateral, third and
fourth ventricles. There is a vascular network surrounded by a single
layer of roughly cuboidal epithelial cells that are joined by tight junc-
tions and make up the blood–CSF barrier (Fig. 1) (Smith et al., 2004).
The vascular endothelial cells differ from those forming the blood–
brain barrier in being fenestrated (Wolburg and Paulus, 2010). Evidence
indicates that endothelial fenestrations, in the kidney and CP, facilitate
the movement of ﬂuid out of the capillaries (Ballermann and Stan,
2007). Between the endothelium and the epithelium is an area of stro-
ma. The choroidal epithelial cells, linked by tight junctions at the apical,
CSF-facing pole of the lateralmembrane (thus accounting for the blood–
Fig. 1. Schema of a cross section of choroid plexus villus: A ring of epithelial cells (single
layer) surrounds the interstitial–vascular core of each villus. Epithelial cells are ‘welded’
together by tight junctions (gray arrowhead) at the apical (CSF-facing)pole. The innermost
capillary (containing red blood cells, RBC), with a fenestrated permeable endothelial
membrane (red arrowhead) and leaky inter-endothelial junctions (blue arrowheads), is
contiguouswith the underlying basement membrane–extracellular matrix. Individual en-
dothelial cells with their nuclei are depicted by lavendar arrowheads. The epithelial
basolateral surface, with its underlying basement membrane, contacts the interstitial
ﬂuid (ISF). The apicalmembrane, containing a lush brush borderwithmicrovilli (white ar-
rowhead) and cilia (black arrowhead), faces the adjacent CSF. CSF formation across the vil-
lus consists of transported Na+, Cl–, HCO3− and water, from plasma to epithelial cells to
ventricles. Inwardmovement (secretion) of plasma solutes occurs transcellularly across ep-
ithelial cells, by a 2-step sequential process: arrow#1, uptake across epithelial basolateral
membrane; and #2, extrusion across apical membrane. Outward movement
(reabsorption) of CSF solutes transcellularly is by apical uptake (arrow #3), followed by
basolateral release (#4). Less extensive diffusion of substances (due to tight junction resis-
tance) occurs paracellularly between epithelial cells (arrow #5). Speciﬁc transporters and
channels at respective membranes of choroidal epithelium (see text) are detailed else-
where (Johanson et al., 2008).
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basolateral interdigitations (Wolburg and Paulus, 2010).
The choroid plexus epithelium has a large mitochondrial content
that is ~12–15% of adult cell volume (Cornford et al., 1997), consistent
with the high energy demand for transepithelial transport. Numerous
mitochondria are close to the apical brush border, presumably for ener-
gizing a plethora of secretory mechanisms [e.g., for the peptides ﬁbro-
blast growth factor-2, arginine vasopressin & insulin-like growth
factor-II (Chodobski and Szmydynger-Chodobska, 2001; Walter et al.,
1999), and the proteins transthyretin, cystatin C & insulin-like growth
factor binding protein-2 (Aldred et al., 1995)]; as well as reabsorptive
transporters that regulate CSF concentrations of certain substances
[e.g., for iodide, potassium & amino acids] (Davson et al., 1987). Thus
the brush border is studded with an array of diversely-functioning
transporters that bidirectionally move various ions and molecules be-
tween blood and ventricular CSF.
Human CP expresses a wide range of transporters (Damkier et al.,
2013). Many of these are asymmetrically distributed between apical
and basolateral membranes indicating involvement in vectorial trans-
port (Spector and Johanson, 2010). The secretory inﬂux of ions into
CSF greatly exceeds the reabsorptive ion efﬂux from the ventricles; con-
sequently, the net formation of CSF. Ion transporters and channels in the
brush border include those for Na+, K+, Cl−, HCO3−, Ca++ and Mg++that operate in the processes of CSF formation and homeostasis
(Damkier et al., 2013).
Choroid plexusmicrovilli have amajor impact on apical surface area,
and thus the capacity to transport. Using stereology on electron micro-
graphs, Keep et al. estimated an apical surface area-to-epithelium vol-
ume ratio of ~3.3 μm2/um3 in the rat (Keep and Jones, 1990; Keep
et al., 1986), i.e., ~30 fold greater than expected from a 10-μm cuboidal
cell with no microvilli. This equates to a total apical surface area of
~75 cm2 in the rat (Keep and Jones, 1990), which is ~50% of the collec-
tive luminal area of the inner wall of cerebral capillaries. Estimates of
choroidal apical surface area, using electron microscopy, have also
beenmade. Examining a variety ofmammalian species, including sever-
al primates, Cornford and colleagues found a ~10-fold increase in apical
surface area due to microvilli (Cornford et al., 1997). By scaling the rat
CP data of Keep and colleagues to human CP (choroid plexus weights
of ~3 mg and 2 g, respectively), this calculation results in an approxi-
mate total apical membrane of 5 m2. With the data of Cornford et al.,
the choroidal area is ~2 m2 (Cornford et al., 1997). Signiﬁcantly, these
more recently-assessed human CP numbers for surface area (2 to
5 m2) are orders of magnitude greater than the 0.02 m2 described
earlier for human CP (Dohrmann, 1970). Unfortunately, the older,
minimal ﬁgure of 0.02 m2 has been repeatedly used in the literature to
compare human CP vs. BBB surface area (~10 m2), thereby grossly
underestimating the potential importance of CP for CNS transport phe-
nomena (Tang et al., 2014). Epithelial interdigitations increase the
basolateral surface area/volume ratio to ~1.1 μm2/um3 in the rat. More-
over, such interdigitations critically amplify areas where local solute
concentration gradients (Diamond, 1971) are generated as the ‘osmot-
ic-driver’ in the CSF secretory process.
Apart from electron microscopy evidence, the electrophysiological
measurements of cell capacitance also enable an estimate of cell surface
area. The surface elaborations (microvilli and interdigitations) increased
rat CP epithelial area (apical + basolateral) by ~10-fold (Speake and
Brown, 2004). This is similar to the increase in apical + basolateral sur-
face area estimated by Keep and colleagues using a morphometric ap-
proach (~7 fold) (Keep and Jones, 1990; Keep et al., 1986). Altogether,
the currently-documented surface area data reinforce the argument for
a substantial ﬂux of solutes and water, from plasma through CP epitheli-
um to the ventricles.
Cerebrospinal ﬂuid secretion by CP
The great surface area of the CP external limitingmembranes (Smith
et al., 2004), facing the blood as well as CSF, enables the robust transfer
of osmotically-active ions that precedes the movement of water. At the
basal interstitial side, Na+ and Cl− are carried into human choroid epi-
thelial cells by membrane-bound exchangers such as Cl−–HCO3− and
the Na+-linked Cl+–HCO3− importer (Praetorius et al., 2004). Apical
Na+–K+-ATPase in CP (Vates et al., 1964) uses ATP substrate to extrude
Na+, a process for driving ﬂuid formation andmaintaining a Na+ trans-
membrane gradient that facilitates solute transfer into and out of
epithelial cells. Carrier-mediated mechanisms export Na+, K+, and
Cl− into CSF by way of active transport via the Na+–K+ pump, Na+–
K+–Cl− cotransport (Keep et al., 1994) and electrogenic NaHCO3
cotransport (sla4a5). Outward diffusion of K+, Cl−, andHCO3− from cho-
roid cell into CSF also occurs, i.e., through apical ion channels down their
respective electrochemical gradients (Millar et al., 2007). Consequently,
the passive distribution of water into the ventricles osmotically follows
the net transport of inorganic ions into CSF, i.e., a dragging effect. Ven-
tricular ﬂuid formation is thus a composite of numerous solute and
water translocation phenomena in CP. In humans the continuous for-
mation rate of CSF varies diurnally between 0.2 and 1.0 ml/min, more
at night (Nilsson et al., 1994).
Ion trafﬁcking through CP of the BCSFB has been analyzed by
radiolabeled tracer transport, autoradiographic mapping, electrophysi-
ologic patch clamping, and with drugs that inhibit/block carriers or
Fig. 2. Transfer coefﬁcients for 22Na and 36Cl uptake by adult rat brain and cisternal CSF.
Tracer 22Na or 36Cl were injected i.v. for 10 min (to assure unidirectional inﬂux), and
then the animal was killed. Means with standard errors are for n = 4 to 6 rats. Mean k
values for CSF (for both 22Na and 36Cl) were signiﬁcantly greater (P b 0.05) than corre-
sponding k values in all brain regions analyzed.
With permission, from Smith and Rapoport (1986).
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been diuretic agents that reduce CSF formation by slowing ion transport
across CP (Davson and Segal, 1970; Javaheri and Wagner, 1993;
McCarthy and Reed, 1974; Murphy and Johanson, 1990; Praetorius
and Nielsen, 2006; Smith and Johanson, 1980, 1991). Clearly, the phar-
macologic inhibitory linkage in the CP–CSF nexus is consistent with
physiologic coupling of CP ion transport to CSF formation.
Direct studies have been performed on functionally-isolated lateral
CP from which nascent CSF secretions were collected by micropipet
(de Rougemont et al., 1960) or from a chamber (Miner and Reed,
1972). Moreover, the extracorporeal CP preparation in sheep has
furnished evidence, by direct ﬂuid sampling, for CSF elaboration (Chen
et al., 2010). Thus, all three abovementioned experiments performed in
live animals demonstrated continually-secreted CSF by CP. Furthermore,
an in vitro observation, made from measurements of CSF secretion by a
monolayer of CP epithelial cells in a transwell, has corroborated the
in vivo assessments (Hakvoort et al., 1998). These independent lines of
evidence, i.e., ﬂuid exudates collected directly from secreting apical
membranes of different species, preparations and sampling techniques,
collectively indicate that CP is a primary source of CSF.
Chemical analyses of isolated choroidal tissue secretions revealed a
composition similar to ventricular CSF from animals and humans (de
Rougemont et al., 1960; Miner and Reed, 1972). When the concentra-
tions of Na+, K+, and Cl− and divalent ions in CSF [either nascent ﬂuid
adjacent to CP or large-cavity ventricular CSF] were compared to corre-
sponding concentrations in a plasma ultraﬁltrate, and a CSF-to-plasma
potential difference of 5 mV CSF-positive factored, Davson and col-
leagues determined from Nernst equation analysis of electrochemical
ion gradients that CSF is an active secretion of CP (Davson et al., 1987).
A vascular line of evidence, independent of CSF concentration analy-
sis, has convincingly revealed that CP turnsﬂuid over into the ventricles.
The great production of CSF necessitates brisk choroidal blood ﬂow to
supply water and ions for epithelial ﬂuid formation. Indeed, the rate of
vascular perfusion of the choroid plexuses, i.e., ~4 ml/min/g (Faraci
et al., 1990), is ~5× greater than mean blood ﬂow to brain in ml/min/
g. As blood courses through the plexus, the hematocrit increases as
ﬂuid in plasma is extracted from the capillary bed; thus, choroidal
venous-to-arterial hematocrit is ~1.15 (Welch, 1963). By cinematically
observing the transit rate of an injected oil particle, Welch and col-
leagues determined CP blood ﬂow; then, by combiningﬂow and hemat-
ocrit data, they calculated a CP secretion of 0.37 ml/min/g (Welch,
1963). The ﬁgure of ~0.4 ml/min/g is similar to estimates in ventricu-
lar–cisternal perfusion studies of indicator dilution (Bradbury and
Davson, 1964). Signiﬁcantly, these collective data indicate that most of
theﬂuid secretion into the ventricles ofmammals stems from the CP tis-
sues (Davson et al., 1987). Moreover, the isolated CP–CSF perfusion sys-
tem in sheep has produced similar ﬁndings (Chen et al., 2010; Thomas
et al., 2001).
Kinetic analyses of uptake of radiolabeled 22Na and 36Cl into CSF
from plasma provide evidence for CP as a major ﬂuid generator in the
CNS. Uptake curves, i.e., the volume of distribution of 22Na or 36Cl into
CSF as a function of exposure time (integrated plasma concentration
of radiolabeled ion) reveal by a curve ‘stripping’ procedure both a fast-
and slow-component of CSF uptake. The fast-component or major ﬂux
of Na+ and Cl− uptake by CSF is via CP because it is inhibited by
acetazolamide, which interferes with CP ion transport (Smith and
Johanson, 1980). Interestingly, acetazolamide does not inhibit tracer
Na+ and Cl− permeation at the BBB in fronto-parietal cortex
(Murphy and Johanson, 1989; Smith and Rapoport, 1986) because
the cerebral capillaries lack the copious carbonic anhydrase activity
that drives ion and water movement across BCSFB. Moreover, the
fast-component of 22Na and 36Cl across CP is not found in infant rat
CSF (Smith et al., 1982) where CP active Na+ secretory mechanisms
and carbonic anhydrase-generating HCO3− are at smaller capacities
(Johanson et al., 1992; Parmelee and Johanson, 1989). The smaller
slow-component of CSF Na+ and Cl− uptake in adults may be due toparacellular diffusion between CP epithelial cells or to ion penetration
at extra-choroidal sites of ﬂuid formation.
Autoradiography is useful in tracking movements of solutes, e.g.
radiolabeled ions andmicronutrients, among anatomical compartments
in CNS. 14C-ascorbate, administered intravenously, was shown by auto-
radiographic mapping (Hammarstrom, 1966) to penetrate rapidly via
carrier into CP and then distribute extensively throughout the ventricles
and surrounding ependymal and periventricular brain regions; and,
later, deep into brain substance from the CSF (Spector, 1981; Spector
and Greene, 1977). In contrast, there was concurrently negligible per-
meation of plasma 14C-ascorbate across BBB to various cortical regions.
An autoradiographic approachwas also used to track earlymovement
(0–30min) of carrier-mediated 22Na and 36Cl across CNSbarriers after in-
travenous loading (Smith and Rapoport, 1986). An autoradiographic pat-
tern of distribution resembling 14C-ascorbate (Hammarstrom, 1966)was
found for tracer 22Na and 36Cl. Accordingly, ion carriers in CP rapidly
translocated intravenously-injected 22Na and 36Cl into CSF (Fig. 2) with
transfer coefﬁcients of ~40 × 10−5 s−1, corresponding in magnitude to
the rat CSF secretion rate (Welch, 1975); contrastingly, plasma-borne
22Na and 36Cl slowly permeated the BBB (frontal cortex, distant from
CSF), with coefﬁcients of only 1–2 × 10−5 s−1. Cerebrovascular perme-
ability coefﬁcients for 22Na and 36Clwere ~200 times greater at the CP ep-
ithelium (BCSFB) than at frontal cortex (BBB). This great difference in
plasma ion penetration at the two barriers reﬂects the fact that salt-
containing ﬂuid throughput at CP, i.e., the predominant CSF-producing
organ, is much greater than across brain capillaries.
Rapid transport of 22Na and 36Cl across the BCSFB (much faster than
at BBB) set up a concentration gradient for these tracer ions, from CSF to
brain extracellular ﬂuid, to diffuse from ventricles and cisterna magna
into adjacent brain (Fig. 3). Consequently, brain regions near CSF
(such as thalamus and hypothalamus) substantially took up 36Cl from
the ventricles (which received tracer from CP secretion), whereas fron-
tal cortex (distant fromCP-CSF) took up far less tracer, i.e., mainly across
cortical capillaries (Figs. 2 and 3). To emphasize the dominant inﬂuence
of the BCSFB vs. BBB uptake from blood, 36Cl movement from ventricles
into brain was blunted by acetazolamide-inhibited 36Cl transport at CP
(Fig. 4). Thus, with CSF formation inhibited by acetazolamide, there
was a sharp decrease in the availability of 36Cl in CSF to penetrate the
ependyma and distribute into various brain regions. Acetazolamide
(which does not alter BBB ion transport) had the least impact on 36Cl
uptake in cortical regions farthest away from the CP tissues that were
pharmacologically inhibited. Collectively, the uptake kinetics of 22Na
and 36Cl, i.e., the ‘surrogate’ osmotic (salt) markers for accompanying
Fig. 3. Time course of changes in 36Cl activity in rat plasma and CNS regions following i.v.
injection of tracer. Note logarithmic scale on y-axis. The CSF uptake curve (ﬂux across CP)
is distinguished by relatively rapid uptake from plasma, with which it nearly equilibrates.
In contrast, 36Cl uptake by frontal cortex (distant from CP) is substantially less due to slow
permeation of tracer across BBB. The thalamic–hypothalamic region had intermediate up-
take of Cl, receiving some tracer across BBB but an additional fraction from CSF via ion
transport across CP tissues into ventricles.
With permission, from Smith and Rapoport (1986).
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evidence that ventricular CSF (99% water) derives mainly from CP rath-
er than distant cerebral microvessels.Fig. 4. Effect of acetazolamide, a CP HCO3− and Cl− transport inhibitor of CSF formation, on
36Cl uptake by adult rat CNS regions. Acetazolamide (20 mg/kg, i.p.) reduced by N30% the
36Cl uptake by CSF fromplasma (P b 0.05); consequently, several regions near CSF (HC, OB,
CN, TH, MB, CR, PM, SC) received less 36Cl (*P b 0.05) from the ventricles in which CPs are
suspended. Cortical regions distant from CP–CSF, e.g. FC, PC and OC, were not affected (in
terms of 36Cl uptake) by acetazolamide-inhibited CSF formation, which is directly propor-
tional to blood-to-CP-to-ventricle transport of 36Cl. Means and SEM are for 8 animals. Ac-
etazolamide thus demonstrates that brain regions near ventricles take up substantial
amounts of 36Cl actively transported across CP as CSF formation. FC, frontal cortex; PC, pa-
rietal cortex; OC, occipital cortex; HC, hippocampus; OB, olfactory bulb; CN, caudate nucle-
us; TH, thalamus; MB, mid-brain-colliculi; CR, cerebellum; PM, pons-medulla; SC, spinal
cord.
With permission, from Smith and Rapoport (1986).In addition to physiologic transport and biochemical enzymatic evi-
dence, there is anatomical and biophysical support for CP as the site that
actively forms CSF. Cultured monolayers of choroid epithelial cells,
inserted in trans-wells as a sheet between compartments correspond-
ing to the basal and apical ﬂuid environments, enable experimental
analyses of molecular and biophysical properties. Accordingly, the
structural polarization of plasma- and ventricle-facing membranes of
the CP epithelium allows segregation of transporter arrays that effect
CSF homeostatic transport and secretory phenomena. Such in vitro
transport studies show a net ﬂux of solutes for CNS homeostasis,
e.g., vitamins and ions, from the basal to apical surface, and the unidirec-
tional secretion of CSF across the epithelial ventricular face (Angeletti
et al., 1997; Angelow et al., 2003; Hakvoort et al., 1998).
A signiﬁcant biophysicalphenomenon associatedwith CSF formation
is that the CP epithelial cell monolayer in culture secretes a column of
ﬂuid from the apical membrane that is several centimeters in height.
The ability of isolated CP to elaborate ﬂuid against a considerable hydro-
static pressure, i.e., an appreciable ﬂuid column above the trans-well
chamber (Hakvoort et al., 1998), is direct evidence for actively-
secreted CSF. The aforementioned biochemical and biophysical evi-
dence for active ﬂuid formation in the CNS is unique for CP, in that com-
parable phenomena have not been described for BBB and ependymal
interfaces. Overall, these data show that ventricular ﬂuid originates
preponderantly from CP, not mainly from brain capillaries as main-
tained by some (Oreskovic and Klarica, 2010). Choroidally-derived CSF
is unequivocally, then, a large component of the ventricular ﬂuid
ﬂowing down the traditionally-recognized drainage pathways
(Johanson et al., 2008). CSF-injected dyes/markers reveal rapid bulk
ﬂow from lateral ventricles or subarachnoid space, to exit sites at the
arachnoidal interfaces with venous sinuses, and nasal submucosa into
deep cervical lymph (Johnston et al., 2004, 2005; Kapoor et al., 2008;
Pollay, 2010). Rapid CSF ﬂow down the neuraxis is seen from distribu-
tion of radiolabelled-peptides and -nonelectrolytes, convected within
minutes to hours from lateral ventricles to subarachnoid regions includ-
ing Virchow–Robin spaces, as well as cranial/spinal nerve root drainage
sites (Bradbury and Cole, 1980; Ghersi-Egea et al., 1996; Nagaraja et al.,
2005; Proescholdt et al., 2000).
Is there also a signiﬁcant extrachoroidal source of CSF-like ﬂuid?
Cerebral capillaries (BBB), the ependymal wall (Pollay and Curl, 1967),
the pia-glia, and the subarachnoidal arterioles and veins are candidate
sites but with minimal documented evidence (Davson et al., 1987).
Studies of CNSwater ﬂux and exchange, in normal and pathologic states
(Buishas et al., 2014), are important in considering alternative or
extrachoroidal sites of ﬂuid formation. As noted above, pioneering stud-
ies (Sweet et al., 1950) demonstrated that heavy water (deuterium
oxide) rapidly penetrates from blood into brain and CSF of humans
many times faster than CSF formation. Similarly, Oldendorf showed
that, in one pass of the circulation through rat brain, most plasma
water exchanges with the brain and CSF water. Water ﬂowing rapidly
out of a cerebrovascular bed on the arterial side may then be readily
reabsorbed, due to a greater downstream capillary osmotic pressure,
at the venous side of that capillary bed; as a result, there would be no
net active formation of ﬂuid in the brain interstitium such as occurs
with CSF in the ventricles. Allusion has been made to CSF formation by
brain capillary endothelium (Bateman and Brown, 2012), but there is
no clear evidence for this; accordingly, the term ‘CSF formation’ should
be reserved for the product of CP epithelial cells. To reiterate, the proliﬁc
brain capillarywater turnover (Brinker et al., 2014) (with no known net
formation of ﬂuid within the interstices) is distinctly different from ac-
tive transport-linked, carbonic anhydrase-catalyzed, salt-containing
CSF formation by CP epithelium (Johanson et al., 1992). There is long-
standing recognition that CP is the source of energy-requiring CSF for-
mation and pressure generation in the ventricles (Netsky and
Shuangshoti, 1975), and modern physiologic and molecular techniques
continually substantiate this concept (Damkier et al., 2013; Millar et al.,
2007).
83R. Spector et al. / Experimental Neurology 267 (2015) 78–86Surprisingly, Oreskovic and Klarica (2010) concluded thatmost salt-
containing ventricular ﬂuid does not derive from CP but rather derives
from cerebral capillaries in the brain. Certainly, as discussed above,
there is rapid and diffusive exchange of H2O between blood, brain and
CSF. However, Oreskovic and Klarica do not address the overwhelming
evidence for actively-secreted CSF by CP, i.e., a ﬂuid composed of salts,
vitamins, hormones and proteins; signiﬁcantly, the active elaboration
of CSF has been the classical view for six decades. The Oreskovic
model, thus minimizing the role of ﬂuid generation at the BCSFB inter-
face,was built partly fromdata obtained largely fromventricular–cister-
nal perfusions and cerebral aqueduct catheterization in adult catswhere
negligible CSFﬂowwas found; insufﬁcient datawere presented on their
anesthetized, heavily-instrumented preparations, e.g.,were their exper-
imental animals controlled for temperature, blood pressure and osmotic
pressure? Extraordinary new theories, e.g. that CP does not preponder-
antly secrete CSF, require extraordinary new evidence.
On the other hand, there is substantial evidence from earlier well-
controlled ventricular–cisternal perfusions (in rats, rabbits and cats) for
intraventricular CSF formation and ﬂow down the aqueduct (Davson
et al., 1987). For example, perfusion experiments in 35 cats generated un-
equivocal evidence that CSF is made in the ventricles but not the sub-
arachnoid space (Lorenzo and Snodgrass, 1972). In each cat, they
performed ventricular–subarachnoid (VS) perfusion followed by ventric-
ular–cisternal (VC) perfusion, using 131I-labeled albumin (mw68,000) as
the perfusion ﬂuid indicator for dilution to reﬂect net CSF formation. That
no CSF formation was found in the subarachnoid space (Lorenzo and
Snodgrass, 1972) counters the argument of Oreskovic and Klarica
(2010) that the indicator dilution technique is artefactual (Oreskovic
and Klarica, 2014a) due in part to loss of indicator from perfusion ﬂuid
to brain. If the latter were true, in the 1972 study by Lorenzo and
Snodgrass where the surface area of CSF-contacting brain (ependyma
plus pia) in the VS perfusions was ~3× that of the VC perfusions, one
would have expected much more apparent (calculated) CSF production
in the VS experiments than in the VC perfusions alone. In actuality,
there was no detected production of CSF in the subarachnoid spaces
(that lack CP tissues). These data conclusively show: i) the absence of
CSF formation in the cat subarachnoid space, and ii) the reliability of
the indicator dilution methodology with albumin. Moreover, multiple
MRI studies in adult humans have consistently found net CSF ﬂow
down the aqueduct (Bateman and Brown, 2012).
Another matter being challenged is whether CSF is actively secreted
mainly by CP (Oreskovic and Klarica, 2010, 2014b). For many decades,
there has been widespread agreement that CP epithelium translocates
ionic salts (e.g., KCl, and NaHCO3) and thatwater is entrained (“dragged
along”) into the ventricles. This substantial energy-requiring choroidal
ﬂuid production is unique to the BCSFB, when compared to its absence
or much smaller active ﬂuid-making (ion-transporting) capacity at
other CNS transport interfaces. Indeed, tracer kinetic analyses have
quantiﬁed (Smith and Rapoport, 1986) that NaCl in CSF has penetrated
largely from the blood via CP, rather than across cerebral capillaries
which are 2 to 3 orders of magnitude less permeable to plasma Na+
and Cl− (Fig. 2).
Furthermore, Oreskovic and Klarica (2010) do not address much of
the information cited above: CP sla4a5 KO mice with CSF diminution,
patients with CP hyperplasia and overproduction of CSF cured by CP ex-
tirpation, the CP as a ﬂuid secretory organ, etc. In over a decade no one
has reproduced their unexpected ﬁnding that in adult cats no CSF ﬂows
down through the aqueduct of Sylvius (Oreskovikic et al., 2005). Still, it
is possible that the brain actively makes small amounts of a salt-
containing ﬂuid similar in composition to CSF, e.g. at the BBB (Cserr,
1988); however, there is scarce evidence, especially for humans, that
the BBB rather than CP actively forms most of the salt-containing CSF
in the mammalian ventricles.
A new MRI technique (JJVCPE imaging) allows the monitoring of
water ﬂux from blood into the CSF compartment. When applied to
mice in which AQP-1 or AQP-4 was knocked out, Igarashi et al.measured water inﬂux into the 3rd ventricle (Igarashi et al., 2014).
These data showed that AQP-4 (outside the CP) facilitates unidirectional
water ﬂow into the ventricles but AQP-1 knockout mice were no differ-
ent than controls. The results with AQP-1 are entirely expected since
for decades unilateral water inﬂux from blood into the ventricles has
been known to be independent of AQP-1, as noted above, since there
is no AQP-1 in brain capillaries and basal CP epithelium. The relevance
of these results in mice to humans is unknown. In view of the limited
blood ﬂow through CP as opposed to the brain, it is likely (but quantita-
tively unknown) that a substantial portion of the exchange of water
between blood and ventricles comes from the brain capillaries sur-
rounding the ventricles. In summary, it is clear that what Igarashi
et al. (2014) measured is water inﬂux into the third ventricle, not CSF
production, since little CSF is formed in the short time frame of these ex-
periments and, as noted above, water ﬂuxes (exchange) into CSF and
brain are orders of magnitude more than CSF production.
Exactly where and how water is osmotically dragged through CP in
CSF production is uncertain but apical AQP-1 may play a small role. In
this regard, Zeuthen and colleagues have described two pathways of
water movement across CP, one passive (channels) and the othermedi-
ated by water cotransport with K+ and Cl− in the ventricular (CSF-fac-
ing) membrane (MacAulay and Zeuthen, 2010; Zeuthen, 1994).
A plethora of evidence, then, procured by a variety of techniques and
preparations, abundantly clariﬁes that CP continuously secretes CSF, a
salt solution, into the cerebral ventricles (Johanson et al., 2008). In
humans there is a clear diurnal pattern (Nilsson et al., 1992). Vigorous
choroidal blood ﬂow, together with the activities of key transport en-
zymes – Na+–K+-ATPase and carbonic anhydrase – drives the CP-
manufactured CSF (containing Na+, Cl−, HCO3−) into the four ventricles
(Lorenzo and Snodgrass, 1972). Transcriptome analysis of Na–K-ATPase
isoforms and carbonic anhydrase 2 in rat CP, both integral to CSF forma-
tion, reveals that these key transport enzymes appear (mRNA) in em-
bryonic life (Liddelow et al., 2013); and thereafter their expression is
augmented postnatally as CSF formation and pressure continuously
rise to the adult level. It is impressive that CP can actively secrete CSF
even when a substantial hydrostatic pressure is exerted on choroidal
cells, either perpendicular to the epithelium as a monolayer in a trans-
well in vitro or when freely suspended in the ventricles under elevated
intracranial pressure in situ (as in hydrocephalus).
Themodel presented by us reinforces the classical thinking of CP–CSF
function introduced by Davson andWelch, whereby CP secretes CSF that
ﬂows down the ventriculo–cisternal–subarachnoid space axis (Davson
et al., 1987); this traditional bulk ﬂow model complements the well-
documented concurrent molecular exchanges (including water)
betweenCSF, interstitialﬂuid andbrain capillaries. Thus, the recent atten-
tion to brain microvessel/capillary phenomena helps to relate under-
standing of water/solute dynamics at the BBB to that at the BCSFB
(Bateman and Brown, 2012; Brinker et al., 2014). In line with CP as the
chief source of CSF, our model also explains how removal/ablation of CP
tissue by surgery/cauterization relieves elevated ICP/ventriculomegaly
due to hyperplasia, papilloma or CP carcinoma that overproduce CSF
(Hallaert et al., 2012); or to obstructive hydrocephalus, e.g., aqueductal
block of CSF ﬂow, and relative overproduction of CSF due to obstructed
efﬂuence across drainage sites (Warf et al., 2012). Moreover, recent
modeling shows that some cases of communicatingHC are due to choroi-
dal overproduction of CSF (Bateman and Brown, 2012).
Efﬂux (reabsorptive) transport function of CP
Years ago, the CP was seenmainly as a diffusion barrier to CSF entry.
In some cases, this remains true; but since the 1970s, scores of examples
have emerged to invalidate that notion as a general principle. Accord-
ingly, discoveries of numerous efﬂux and inﬂux transporters as well as
drug metabolizing enzymes in CP have led to a more complex perspec-
tive (Spector and Johanson, 2010). These transporters have roles in reg-
ulating concentrations of endogenousmolecules such as phosphate and
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ically, as exempliﬁed below. For a given molecule or drug, in order to
evaluate its net transport into CSF, it is essential to know its inﬂux rate rel-
ative to its efﬂux rate at the BCSFB. The efﬂux (reabsorptive) rate can be
very substantial, thereby preventing a drug, once transported into CSF,
from attaining a sufﬁciently high therapeutic concentration in CSF.
Case report of meningitis (observed by RS)
In 1969, a 19-year-old healthy Iowa recruit undergoing basic train-
ing in California (before being sent to Vietnam) developed malaise,
fever and was admitted at 5:00 pm. Later, an observant nurse noted
skin petechiae. Blood cultures were obtained and the patient was
begun on 2 g a day (in divided doses) of cephalothin, intravenously,
by the physician on call. That evening, the patient developed a stiff
neck; a lumbar puncture showed many white cells in the CSF and a
few “cocci.” The next morning, the stuporous patient was switched
from cephalothin to penicillin 30million units per day (~30 g of intrave-
nous penicillin G individed doses) by a senior experienced clinician. Un-
fortunately the patient diedwithin 48 h of admission formeningococcal
disease. Why – since hewas started on an antibiotic to which his bacte-
ria were sensitive – did he die?
The answer became scientiﬁcally clear several years later when it
was established that an efﬂux transport carrier (now termed organic
acid transporter 3-OAT3) in the CP (and also to a lesser extent at the
BBB) transports penicillin and similar antibiotics (e.g., cephalothin),
both in vitro and in vivo, out of CSF and brain. In vivo, the efﬂux-rate
of penicillin out of rabbit CSF is fourteen times greater than the inﬂux
rate (Spector, 2010). This is the main reason that the steady-state pen-
icillin G concentration in CSF in rabbits and humans is only ~1% that in
plasma. OAT3 has been cloned, expressed and characterized; and is
present in large amounts on the apical surface of CP (Angeletti et al.,
1997) and on the abluminal side of BBB capillaries in animals and
humans (Spector, 2010). Thus to be effective in the therapy of meningi-
tis, the penicillin and other drugs pumped out of CSF must be given in
massive parenteral doses (to saturate the removal mechanism, thus
allowing more drug to remain in CSF); or antibiotics like imipenem or
ceftriaxone (that are not pumped out of CSF by CP) must be employed
(Spector, 1986). Ceftriaxone is now the drug of choice formany patients
with bacterial meningitis. Standard doses of penicillin (or drugs like
cephalothin) are ineffective in meningitis since they are pumped out
of CSF and, since time is of the essence, must not be used. Would the
aforementioned patient have survived if mega-dose penicillin had
been started earlier? This is not knowable retrospectively but his pros-
pects for survival would have been better.
Another well-characterized system, the oligopeptide transporter
PEPT2, resides on the apical surface of CP and also clears some antibiotics
fromCSF (Shen et al., 2007; Spector, 2010). PEPT2 transports cephalospo-
rins with anα-amino group, such as cefradoxil. Thus, CSF cefradoxil con-
centrations are much lower than plasma concentrations after systemic
administration. Experimentally, CSF cefradoxil concentrations are mark-
edly increased in PEPT2 KOmice (Shen et al., 2007). Accordingly, cepha-
losporins containing α-amino groups are not used to treat meningitis.
Multiple other efﬂux carriers exist in CP that substantially alter the
reabsorptive ﬂux from CSF of many drugs, and natural substances,
e.g., choline (Sweet et al., 2001); this is inconsistent with the old notion
of molecular weight, ionic change and lipid solubility mainly determin-
ing themolecular distribution between CSF and plasma. The readermay
wish to consult the many excellent reviews and books on efﬂux trans-
port out of CSF via CP (Spector and Johanson, 2010; Spector, 2010;
Davson et al., 1987).
Non-ionic inﬂux transport function of CP
For decades it has been recognized that the earlier notion of theCP as
“nourishing liquor” has some, although, limited merit. For example, theCP (not the capillaries at the BBB) transfers folate and vitamin C through
the blood–CSF barrier to achieve a four times higher concentration in
CSF (Spector, 2009). From CSF, the vitamins readily enter brain across
the permeable ependyma and pia-glia. The importance of these systems
is seen in patients with mutations of the proton-coupled folate trans-
porter (PCFT) or the folate receptor alpha (FRα), both transport proteins
being involved in translocating folate through CP from blood into CSF.
Not only do these patients have low folate in the CSF but also they devel-
op devastating neurological disorders, and even death, unless treated
with massive doses of folates (Spector, 2014; Spector and Johanson,
2014). CP also transports other peptides from blood into CSF,
e.g., prolactin and leptin (Thomas et al., 2001). Recent treatises of the
multiple inﬂux, e.g. insulin-like growth factor-I (Carro et al., 2005),
and secretory functions of CP are available (Damkier et al., 2013;
Smith et al., 2004; Spector, 2009).
To recapitulate, the earlier notion that themolecular size, charge and
lipid solubility of many drugs, nutrients and certain proteins are the
principal factors determining passive distribution of many substances
between the CSF, brain and blood, has been supplanted with a more ac-
tive, multi-transporter regulated view of the BCSFB. Moreover, the ac-
tive transport systems for these compounds are clinically relevant in
some cases as per the clinical example above. In fact, many such exam-
ples of carriers are now known to transport drugs in the treatment of
AIDS (Varatharajan and Thomas, 2009), cancer and other disorders.
Similarly there are transporters at the BBB, such as P-glycoprotein
(Cirrito et al., 2005), that in cooperation with the CP protect the CNS
or in other cases, e.g. the GLUT-1 transporter (Farrell et al., 1992),
provide glucose to nourish the brain (Spector, 2009; Spector and
Johanson, 2010).
Penetration of substances from the CSF into the brain
There has been some reluctance in the CSF ﬁeld, even recently (Tang
et al., 2014), to accept the idea that solutes can penetrate deeply into the
brain from the ventricles. This notion, also needing revision, has arisen
from data obtained in acute ventricular perfusions or injections (a few
hours) wherein the test substance was rapidly actively reabsorbed or,
even if not actively removed, swept away by bulk ﬂow (not having ad-
equate time to diffuse deeply into brain from a signiﬁcant concentration
‘point source’ in ventricular CSF) (Nagaraja et al., 2005).
Based on a few examples, Pardridge (2012) suggested that small
molecules including drugs do not penetrate signiﬁcantly from the CSF
into the brain, e.g., after transfer by CP from the blood into the CSF or
by direct injection into the ventricles. He used lipid-soluble substances
and methotrexate as examples. It is true that lipid-soluble substances
readily traverse biological membranes and methotrexate, a water-
soluble compound, leaves CSF rapidly. However, methotrexate, we
now know, is pumped out of the CSF and brain by speciﬁc barrier trans-
porters (Ohtsuki et al., 2003) and, in fact, makes the case prototypically
for transporters determining drug distribution, not just passive forces. A
similar situation exists with leucine which is also removed, by a satura-
ble amino acid carrier, out of the subarachnoid space (Lorenzo and
Snodgrass, 1972) and ventricular CSF.
In actuality, though, some molecules in CSF can penetrate deeply
into the substance of the brain. This was shown in 1966 with vitamin
C in mice (Hammarstrom, 1966), later with sucrose in cats (Lorenzo
and Snodgrass, 1972), and later still with mannitol and vitamin C in
rabbits (Spector, 1981). The process of brain penetration of molecules
is slow — days, not hours and there is some diurnal variation. Subse-
quently, as noted above, NaCl and even inulin (mw ~5000) were
shown to gradually enter the deep substance of the brain from CSF via
diffusion and propulsion (convection) by the dynamic arterial pulsa-
tions in the brain/CSF visible by micro-video probes in the ventricles.
It is worth noting that sucrose (mw 360), mannitol (mw 180) and inu-
lin, unlike vitamin C, are all passively distributed in the CNS, mainly in
the CSF-extracellular space of the brain (Johanson, 1980; Lorenzo and
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quantitatively, a major proportion of the NaCl in the extracellular
space of brain comes from the CSF via active transport across CP, not di-
rectly through the BBB (Smith and Rapoport, 1986). Overall some ions,
micronutrients and drugs (not actively reabsorbed by CP or the BBB)
can penetrate deeply into brain from ventricular CSF.
Extirpation of CP
Several decades ago, Klosovskii showed that ‘complete’ extirpation
of CP in neonatal dogs led to deﬁcient brain development and function
(Klosovskii, 1963). Because damage to the canine brains occurred dur-
ing the choroid plexectomies, these and other similar experiments can-
not be considered deﬁnitive. However,we nowknow that eradication of
just one function in CP, e.g., folate transport by KO of either PCFT or FRα
in humans, leads to severe neurological disease or death as discussed
above (Spector, 2009, 2014; Spector and Johanson, 2014).
This raises a question about the long-term effects of extirpating the
two lateral CPs as a treatment for absolute or relative overproduction
of CSF in hydrocephalus (Pliushcheva and Shakhnovich, 1994)— either
the communicating or obstructive type. Without doubt, in many cases
where shunting is neither feasible nor performed, lateral CP extirpation
seems to “work”with amelioration of the signs and symptoms of hydro-
cephalus (Bateman and Brown, 2012; Hallaert et al., 2012; Warf et al.,
2012). The improvement mechanism is clear. Removal of the lateral
CP tissues decreases total CSF production, in many cases presumably
by ~50% (lateral ventricle CPs are ~1/2 the total CP mass), thereby re-
ducing the volume and relieving the pressure in the ventricular system.
Moreover, it is formally possible that there will not be long-term conse-
quences to brain structure and function (by analogywith the removal of
one of the two kidneys) since ~50% of CP tissue is not removed. Howev-
er, this hypothesis needs to be tested rigorously in carefully-controlled
trials over extended time periods, e.g. against third ventriculostomy or
shunting (Souweidane, 2014; Stone and Warf, 2014).
Conclusions
In summary, the CP of mammals and humans is a generously-
perfused organ in the brain with an enormous surface area. The CP se-
cretes most of the CSF that contains nourishing molecules, e.g., vitamins
and transthyretin, able to penetrate from CSF deep into the substance of
brain (Damkier et al., 2013; Spector, 2009). Moreover, the CP also
pumps out of CSF many clinically important drugs such as penicillin,
and polarized endogenous and exogenous endogenous molecules not
needed by the brain (Miller, 2004; Spector and Johanson, 2013). Not
only does the CPmanufacture CSF for the brain, e.g., for buoyancy protec-
tion against physical blows, but also it provides continuous and fresh CSF
for brain ion and molecular homeostasis. Without CP and its vital CSF
transport systems, e.g. for folate and vitamin C (Spector and Johanson,
2014), the brain cannot live.
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